Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Kidney Transplantation

  Free Subscription


Articles published in Transpl Int

Retrieve available abstracts of 119 articles:
HTML format
Text format



Single Articles


    October 2017
  1. DORR CR, Oetting WS, Jacobson PA, Israni AK, et al
    Genetics of Acute Rejection after Kidney Transplantation.
    Transpl Int. 2017 Oct 14. doi: 10.1111/tri.13084.
    PubMed     Text format     Abstract available


  2. MOLNAR MZ
    Is kidney transplantation safe after careful selection of the recipients with a history of psychotic disorder?
    Transpl Int. 2017 Oct 11. doi: 10.1111/tri.13082.
    PubMed     Text format     Abstract available


  3. DHARNIDHARKA VR, Naik AS, Axelrod DA, Schnitzler MA, et al
    Center practice drives variation in choice of U.S. kidney transplant induction therapy: A retrospective analysis of contemporary practice.
    Transpl Int. 2017 Oct 7. doi: 10.1111/tri.13079.
    PubMed     Text format     Abstract available


    September 2017
  4. KOFMAN T, Pourcine F, Canoui-Poitrine F, Kamar N, et al
    Safety of renal transplantation in patients with bipolar or psychotic disorders: a retrospective study.
    Transpl Int. 2017 Sep 25. doi: 10.1111/tri.13078.
    PubMed     Text format     Abstract available


  5. FERNANDEZ-RUIZ M, Origuen J, Lora D, Lopez-Medrano F, et al
    Herpes zoster in kidney transplant recipients: protective effect of anti-CMV prophylaxis and NK cells count. A single-center cohort study.
    Transpl Int. 2017 Sep 22. doi: 10.1111/tri.13076.
    PubMed     Text format     Abstract available


  6. LIM WH, Wong G
    The "Cold" Hard Facts - Seasonal Variation in Outcomes After Kidney Transplantation.
    Transpl Int. 2017 Sep 22. doi: 10.1111/tri.13077.
    PubMed     Text format     Abstract available


  7. LEEAPHORN N, Garg N, Khankin EV, Cardarelli F, et al
    Recurrence of IgA nephropathy after kidney transplantation in steroid continuation versus early steroid-withdrawal regimens: a retrospective analysis of the UNOS/OPTN database.
    Transpl Int. 2017 Sep 19. doi: 10.1111/tri.13075.
    PubMed     Text format     Abstract available


  8. STAPLETON CP, Conlon PJ, Phelan PJ
    Using omics to explore complications of kidney transplantation.
    Transpl Int. 2017 Sep 11. doi: 10.1111/tri.13067.
    PubMed     Text format     Abstract available


  9. ASTOR BC, Melamed ML, Mandelbrot DA, Djamali A, et al
    Seasonality of Mortality and Graft Failure among Kidney Transplant Recipients in the US.
    Transpl Int. 2017 Sep 4. doi: 10.1111/tri.13047.
    PubMed     Text format     Abstract available


  10. FILLER G, Ferris M
    We have to do more for former paediatric renal transplant recipients!
    Transpl Int. 2017 Sep 2. doi: 10.1111/tri.13058.
    PubMed     Text format     Abstract available


  11. GRIMBERT P
    Toward a better risk stratification for late antibody-mediated rejection in ABO incompatible kidney recipients.
    Transpl Int. 2017;30:863-864.
    PubMed     Text format    


    August 2017
  12. ENDEN K, Tainio J, Jalanko H, Jahnukainen K, et al
    Lower quality of life in young men after pediatric kidney transplantation when compared to healthy controls and survivors of childhood leukemia - a cross-sectional study.
    Transpl Int. 2017 Aug 29. doi: 10.1111/tri.13040.
    PubMed     Text format     Abstract available


  13. LAUTERIO A, De Carlis R, Di Sandro S, Ferla F, et al
    Bovine pericardium for multiple artery reconstruction in kidney transplantation.
    Transpl Int. 2017 Aug 23. doi: 10.1111/tri.13039.
    PubMed     Text format     Abstract available


  14. KHALID U, Ilham MA, Awad M, Elker D, et al
    Correspondence to: 'Pregnancy outcomes in simultaneous pancreas and kidney transplant recipients: a national French survey study'.
    Transpl Int. 2017 Aug 10. doi: 10.1111/tri.13019.
    PubMed     Text format     Abstract available


  15. LUQUE S, Lucia M, Bestard O
    Refinement of Humoral Immune-monitoring in Kidney Transplantation: the role of "hidden" Alloreactive Memory B cells.
    Transpl Int. 2017 Aug 4. doi: 10.1111/tri.13014.
    PubMed     Text format     Abstract available


  16. ASSALINO M, Hadaya K, Andres A, Berney T, et al
    Discordant rejection in simultaneous pancreas and kidney transplantation: true discordance or analysis artefact ?
    Transpl Int. 2017 Aug 4. doi: 10.1111/tri.13017.
    PubMed     Text format     Abstract available


  17. GAYNOR JJ, Ciancio G
    Clinical depression as an unfavorable prognostic factor following kidney transplantation - How can we explain it?
    Transpl Int. 2017 Aug 4. doi: 10.1111/tri.13012.
    PubMed     Text format     Abstract available


  18. LENTINE KL, Naik AS, Ouseph R, Zhang Z, et al
    Antidepressant medication use before and after kidney transplant: implications for outcomes - A retrospective study.
    Transpl Int. 2017 Aug 3. doi: 10.1111/tri.13006.
    PubMed     Text format     Abstract available


    July 2017
  19. DELTOMBE C, Gillaizeau F, Anglicheau D, Morelon E, et al
    Is Pre-transplant sensitization against Angiotensin II Type1 Receptor still a risk factor of graft and patient outcome in kidney transplantation in the anti HLA Luminex era?
    Transpl Int. 2017 Jul 7. doi: 10.1111/tri.13009.
    PubMed     Text format     Abstract available


  20. TORRES IB, Reisaeter AV, Moreso F, Asberg A, et al
    Tacrolimus and mycophenolate regimen and subclinical tubulo-interstitial inflammation in low immunological risk renal transplants.
    Transpl Int. 2017 Jul 1. doi: 10.1111/tri.13002.
    PubMed     Text format     Abstract available


    June 2017
  21. BOBAN MD, Tiefenthaler M
    Tangential Extraperitoneal Retrorenal (TER) approach: a specified uniform technique for renal transplant biopsy.
    Transpl Int. 2017 Jun 7. doi: 10.1111/tri.12994.
    PubMed     Text format     Abstract available


  22. MORATH C, Zeier M, Susal C
    Increased risk of infection-associated death with incompatible kidney transplantations.
    Transpl Int. 2017 Jun 6. doi: 10.1111/tri.12995.
    PubMed     Text format     Abstract available


  23. WAHBA R, Suwelack B, Arns W, Cakiroglu F, et al
    Rescue Allocation and Recipient Oriented Extended Allocation in kidney transplantation - Influence of the EUROTRANSPLANT allocation system on recipient selection and graft survival for initially non-accepted organs.
    Transpl Int. 2017 Jun 2. doi: 10.1111/tri.12993.
    PubMed     Text format     Abstract available


    May 2017
  24. CREMASCHI L, von Versen R, Benzing T, Wiesener M, et al
    Induction therapy with rabbit antithymocyte globulin versus basiliximab after kidney transplantation: A health economic analysis from a German perspective.
    Transpl Int. 2017 May 27. doi: 10.1111/tri.12991.
    PubMed     Text format     Abstract available


  25. NORMAND G, Brunner F, Badet L, Buron F, et al
    Pregnancy outcomes in simultaneous pancreas and kidney transplant recipients: a national french survey study.
    Transpl Int. 2017 May 13. doi: 10.1111/tri.12983.
    PubMed     Text format     Abstract available


  26. KO EJ, Yu JH, Yang CW, Chung BH, et al
    Clinical outcomes of ABO- and HLA-incompatible kidney transplantation: A nationwide cohort study.
    Transpl Int. 2017 May 11. doi: 10.1111/tri.12979.
    PubMed     Text format     Abstract available


  27. WILLICOMBE M, Goodall D, McLean AG, Taube D, et al
    Alemtuzumab dose adjusted for body weight is associated with earlier lymphocyte repletion and less infective episodes in the first year post renal transplantation.
    Transpl Int. 2017 May 11. doi: 10.1111/tri.12978.
    PubMed     Text format     Abstract available


  28. UPALA S, Sanguankeo A, Panichsillapakit T, Wijarnpreecha K, et al
    Reply to: an evolving understanding of modifiable risk factors for post-transplant mortality.
    Transpl Int. 2017;30:535.
    PubMed     Text format    


  29. RINALDI S, Horne J, Madill J
    An evolving understanding of modifiable risk factors for post-transplant mortality.
    Transpl Int. 2017;30:533-534.
    PubMed     Text format    


    April 2017
  30. GRIMBERT P, Thaunat O
    mTOR inhibitors and risk for chronic antibody-mediated rejection after kidney transplantation: Where are we now?
    Transpl Int. 2017 Apr 26. doi: 10.1111/tri.12975.
    PubMed     Text format     Abstract available


  31. PIHLSTROM HK, Gatti F, Hammarstrom C, Eide IA, et al
    Early introduction of oral paricalcitol in renal transplant recipients. An open-label randomized study.
    Transpl Int. 2017 Apr 24. doi: 10.1111/tri.12973.
    PubMed     Text format     Abstract available


  32. MCCAUGHAN JA, Courtney AE
    Successful kidney transplantation in highly sensitised, ultra-long term dialysis patients.
    Transpl Int. 2017 Apr 18. doi: 10.1111/tri.12970.
    PubMed     Text format     Abstract available


  33. LONZE BE, Bae S, Kraus ES, Holechek MJ, et al
    Outcomes and Risk Stratification for Late Antibody Mediated Rejection in Recipients of ABO-incompatible Kidney Transplants.
    Transpl Int. 2017 Apr 12. doi: 10.1111/tri.12969.
    PubMed     Text format     Abstract available


  34. VANHOVE T, Kinashi H, Nguyen TQ, Metalidis C, et al
    Tubulointerstitial expression and urinary excretion of connective tissue growth factor 3 months after renal transplantation predict interstitial fibrosis and tubular atrophy at 5 years in a retrospective cohort analysis.
    Transpl Int. 2017 Apr 8. doi: 10.1111/tri.12960.
    PubMed     Text format     Abstract available


  35. FERRARI-LACRAZ S
    Donor-specific antibodies' C1q binding: improvement in kidney graft management?
    Transpl Int. 2017;30:344-346.
    PubMed     Text format    


  36. GO H, Shin S, Kim YH, Han DJ, et al
    Refinement of the criteria for ultrastructural peritubular capillary basement membrane multilayering in the diagnosis of chronic active/acute antibody-mediated rejection.
    Transpl Int. 2017;30:398-409.
    PubMed     Text format     Abstract available


  37. AMIN I, Butler AJ, Defries G, Russell NK, et al
    A single-centre experience of Roux-en-Y enteric drainage for pancreas transplantation.
    Transpl Int. 2017;30:410-419.
    PubMed     Text format     Abstract available


    March 2017
  38. FISHMAN JA, Ikle DN, Wilkinson RA
    Discrepant Serological Assays for Pneumococcus in Renal Transplant Recipients.
    Transpl Int. 2017 Mar 27. doi: 10.1111/tri.12959.
    PubMed     Text format     Abstract available


  39. BARLOW AD, Saeb-Parsy K, Watson CJ
    An analysis of the survival outcomes of simultaneous pancreas and kidney transplantation compared to live donor kidney transplantation in patients with type 1 diabetes: a UK Transplant Registry study.
    Transpl Int. 2017 Mar 20. doi: 10.1111/tri.12957.
    PubMed     Text format     Abstract available


  40. MIHALJEVIC AL, Heger P, Dezfouli SA, Golriz M, et al
    Prophylaxis of lymphocele formation after kidney transplantation via peritoneal fenestration: a systematic review.
    Transpl Int. 2017 Mar 14. doi: 10.1111/tri.12952.
    PubMed     Text format     Abstract available


  41. DE BOER JD, Kopp WH, Ooms K, Haase-Kromwijk BJ, et al
    Abdominal organ procurement in the Netherlands - an analysis of quality and clinical impact.
    Transpl Int. 2017;30:288-294.
    PubMed     Text format     Abstract available


  42. MOKTEFI A, Parisot J, Desvaux D, Canoui-Poitrine F, et al
    C1q binding is not an independent risk factor for kidney allograft loss after an acute antibody-mediated rejection episode: a retrospective cohort study.
    Transpl Int. 2017;30:277-287.
    PubMed     Text format     Abstract available


    February 2017
  43. LERCH C, Kanzelmeyer NK, Ahlenstiel-Grunow T, Froede K, et al
    Belatacept after kidney transplantation in adolescents: a retrospective study.
    Transpl Int. 2017 Feb 6. doi: 10.1111/tri.12932.
    PubMed     Text format     Abstract available


    January 2017
  44. TAN SJ, Crosthwaite A, Langsford D, Obeysekere V, et al
    Mineral adaptations following kidney transplantation.
    Transpl Int. 2017 Jan 25. doi: 10.1111/tri.12925.
    PubMed     Text format     Abstract available


  45. HACHEM LD, Ghanekar A, Selzner M, Famure O, et al
    Postoperative Surgical-Site Hemorrhage After Kidney Transplantation: Incidence, Risk Factors, and Outcomes.
    Transpl Int. 2017 Jan 25. doi: 10.1111/tri.12926.
    PubMed     Text format     Abstract available


  46. BERTRAND D, Dehay J, Ott J, Sberro R, et al
    Kidney transplantation in patients with systemic sclerosis: a nationwide multicenter study.
    Transpl Int. 2017 Jan 25. doi: 10.1111/tri.12923.
    PubMed     Text format     Abstract available


  47. SIMKINS J, Morris MI, Abbo LM, Camargo JF, et al
    Severe hypertension after initiation of rifapentine/isoniazid for latent tuberculosis in renal transplant candidates.
    Transpl Int. 2017;30:108-109.
    PubMed     Text format    


  48. PALIN NK, Savikko J, Pasternack A, Rintala JM, et al
    Activin inhibition limits early innate immune response in rat kidney allografts-a pilot study.
    Transpl Int. 2017;30:96-107.
    PubMed     Text format     Abstract available


  49. FINK S, Tsai MH, Schnitzler P, Zeier M, et al
    The Epstein-Barr virus DNA load in the peripheral blood of transplant recipients does not accurately reflect the burden of infected cells.
    Transpl Int. 2017;30:57-67.
    PubMed     Text format     Abstract available


  50. CAILLARD S, Becmeur C, Gautier-Vargas G, Olagne J, et al
    Pre-existing donor-specific antibodies are detrimental to kidney allograft only when persistent after transplantation.
    Transpl Int. 2017;30:29-40.
    PubMed     Text format     Abstract available


    December 2016
  51. JORGENSEN MB, Hornum M, van Hall G, Bistrup C, et al
    The impact of kidney transplantation on insulin sensitivity.
    Transpl Int. 2016 Dec 21. doi: 10.1111/tri.12907.
    PubMed     Text format     Abstract available


    November 2016
  52. VAN LAECKE S, Nagler EV, Peeters P, Verbeke F, et al
    Former smoking and early and long-term graft outcome in renal transplant recipients: a retrospective cohort study.
    Transpl Int. 2016 Nov 28. doi: 10.1111/tri.12897.
    PubMed     Text format     Abstract available


  53. MALIAKKAL JG, Brennan DC, Goss C, Horwedel TA, et al
    Ureteral Stent Placement and Immediate Graft Function are associated with Increased Risk of BK Viremia in the First Year after Kidney Transplantation.
    Transpl Int. 2016 Nov 18. doi: 10.1111/tri.12888.
    PubMed     Text format     Abstract available


  54. KAUKE T, Oberhauser C, Lin V, Coenen M, et al
    De novo donorspecific anti-HLA antibodies after kidney transplantation are associated with impaired graft outcome independently of their C1q-binding ability.
    Transpl Int. 2016 Nov 18. doi: 10.1111/tri.12887.
    PubMed     Text format     Abstract available


    October 2016
  55. DE MEESTER J
    The expanded criteria donor for kidney transplant: not a nearly new car.
    Transpl Int. 2016 Oct 25. doi: 10.1111/tri.12880.
    PubMed     Text format     Abstract available


  56. RUMMO OO, Carmellini M, Rostaing L, Oberbauer R, et al
    ADHERE: Randomized controlled trial comparing renal function in de novo kidney transplant recipients receiving prolonged-release tacrolimus plus MMF or sirolimus.
    Transpl Int. 2016 Oct 18. doi: 10.1111/tri.12878.
    PubMed     Text format     Abstract available


  57. WEITZ M, Sazpinar O, Schmidt M, Neuhaus TJ, et al
    Balancing competing needs in kidney transplantation: Does an allocation system prioritising children affect the renal transplant function?
    Transpl Int. 2016 Oct 12. doi: 10.1111/tri.12874.
    PubMed     Text format     Abstract available


  58. MALHEIRO J, Tafulo S, Dias L, Martins S, et al
    Determining donor-specific antibodies C1q-binding ability improves the prediction of antibody-mediated rejection in HLA-incompatible kidney transplantation.
    Transpl Int. 2016 Oct 7. doi: 10.1111/tri.12873.
    PubMed     Text format     Abstract available


  59. ROSTAING L, Alric L, Kamar N
    Use of direct-acting agents for HCV-positive kidney-transplant candidates and kidney-transplant recipients.
    Transpl Int. 2016 Oct 7. doi: 10.1111/tri.12870.
    PubMed     Text format     Abstract available


  60. BREKKE FB, Waldum-Grevbo B, von der Lippe N, Os I, et al
    The effect of renal transplantation on quality of sleep in former dialysis patients.
    Transpl Int. 2016 Oct 1. doi: 10.1111/tri.12866.
    PubMed     Text format     Abstract available


    September 2016
  61. VAN ITTERSUM FJ, Hemke AC, Dekker FW, Hilbrands LB, et al
    Increased risk of graft failure and mortality in Dutch recipients receiving an Expanded Criteria Donor kidney transplant.
    Transpl Int. 2016 Sep 20. doi: 10.1111/tri.12863.
    PubMed     Text format     Abstract available


  62. CRUZADO JM, Pascual J, Sanchez-Fructuoso A, Seron D, et al
    Controlled randomized study comparing the cardiovascular profile of everolimus with tacrolimus in renal transplantation.
    Transpl Int. 2016 Sep 20. doi: 10.1111/tri.12862.
    PubMed     Text format     Abstract available


  63. SCHACHTNER T, Stein M, Reinke P
    Kidney Transplant Recipients after Nonrenal Solid Organ Transplantation Show Low Alloreactivity but an Increased Risk of Infection.
    Transpl Int. 2016 Sep 17. doi: 10.1111/tri.12856.
    PubMed     Text format     Abstract available


  64. LANFRANCO L, Olle Delahaye P, Dorr G, Del Bello A, et al
    Late isolated ocular toxoplasmosis in a belatacept-treated kidney-transplant patient.
    Transpl Int. 2016 Sep 10. doi: 10.1111/tri.12853.
    PubMed     Text format     Abstract available


    August 2016
  65. DHARNIDHARKA VR, Schnitzler MA, Chen J, Brennan DC, et al
    Differential Risks for Adverse Outcomes 3-Years after Kidney Transplantation Based on Initial Immunosuppression Regimen: A National Study.
    Transpl Int. 2016 Aug 26. doi: 10.1111/tri.12850.
    PubMed     Text format     Abstract available


  66. CERVERA C, Cofan F, Hernandez C, Soy D, et al
    Effect of mTOR inhibitors on CMV infection in kidney transplant recipients receiving polyclonal antilymphocyte globulins: a propensity score-matching analysis.
    Transpl Int. 2016 Aug 26. doi: 10.1111/tri.12848.
    PubMed     Text format     Abstract available


  67. LUQUE Y, Anglicheau D, Rabant M, El Karoui K, et al
    Renal safety of high-dose, sucrose-free intravenous immunoglobulin in kidney transplant recipients: an observational study.
    Transpl Int. 2016 Aug 16. doi: 10.1111/tri.12833.
    PubMed     Text format     Abstract available


  68. EISENGA MF, Minovic I, Berger SP, Kootstra-Ros JE, et al
    Iron Deficiency, Anemia and Mortality in Renal Transplant Recipients.
    Transpl Int. 2016 Aug 12. doi: 10.1111/tri.12821.
    PubMed     Text format     Abstract available


  69. BROCHOT E, Desoutter J, Presne C, De Araujo I, et al
    The association between KIR and KIR ligand genotypes and the likelihood of BK virus replication after kidney transplantation.
    Transpl Int. 2016 Aug 12. doi: 10.1111/tri.12820.
    PubMed     Text format     Abstract available


  70. BRAKEMEIER S, Kannenkeril D, Durr M, Braun T, et al
    Experience with belatacept rescue therapy in kidney transplant recipients.
    Transpl Int. 2016 Aug 12. doi: 10.1111/tri.12822.
    PubMed     Text format     Abstract available


    July 2016
  71. PALOYO S, Sageshima J, Gaynor JJ, Chen L, et al
    Negative Impact of Prolonged Cold Storage Time before Machine Perfusion Preservation in Donation after Circulatory Death Kidney Transplantation.
    Transpl Int. 2016 Jul 16. doi: 10.1111/tri.12818.
    PubMed     Text format     Abstract available


    June 2016
  72. PEREZ-JACOISTE ASIN MA, Fernandez-Ruiz M, Lopez-Medrano F, Aquilino C, et al
    Monitoring of intracellular ATP in CD4+ T-cells to predict the occurrence of cytomegalovirus disease in kidney transplant recipients.
    Transpl Int. 2016 Jun 30. doi: 10.1111/tri.12816.
    PubMed     Text format     Abstract available


  73. CENA T, Musetti C, Quaglia M, Magnani C, et al
    De novo non cutaneous malignancies after kidney transplantation are associated with an increased risk of graft failure: results from a time-dependent analysis on 672 patients.
    Transpl Int. 2016 Jun 25. doi: 10.1111/tri.12813.
    PubMed     Text format     Abstract available


  74. PEDROLLO EF, Correa C, Nicoletto BB, Manfro RC, et al
    Effects of metabolic syndrome on kidney transplantation outcomes: A systematic review and meta-analysis.
    Transpl Int. 2016 Jun 10. doi: 10.1111/tri.12805.
    PubMed     Text format     Abstract available


    May 2016
  75. AITKEN E, Little AM, Clancy M
    Prioritising renal transplantation based on clinical need: The role of an "urgent" kidney waiting list.
    Transpl Int. 2016 May 21. doi: 10.1111/tri.12801.
    PubMed     Text format     Abstract available


  76. BEINHARDT S, Al Zoairy R, Ferenci P, Kozbial K, et al
    DAA-based antiviral treatment of patients with chronic hepatitis C in the pre- and post kidney transplantation setting.
    Transpl Int. 2016 May 20. doi: 10.1111/tri.12799.
    PubMed     Text format     Abstract available


  77. PATEL SJ, Suki WN, Loucks-DeVos J, Graviss EA, et al
    Disparate rates of acute rejection and donor specific antibodies among high-immunologic risk renal transplant subgroups receiving antithymocyte globulin induction.
    Transpl Int. 2016 May 19. doi: 10.1111/tri.12791.
    PubMed     Text format     Abstract available


  78. SHUKER N, Shuker L, van Rosmalen J, Roodnat JI, et al
    A High intra-patient variability in tacrolimus exposure is associated with poor long-term outcome of kidney transplantion.
    Transpl Int. 2016 May 18. doi: 10.1111/tri.12798.
    PubMed     Text format     Abstract available


  79. LACHMANN N, Schonemann C
    Tracing Clinically Relevant HLA Antibodies Prior to Kidney Transplantation.
    Transpl Int. 2016 May 14. doi: 10.1111/tri.12796.
    PubMed     Text format     Abstract available


    April 2016
  80. BACHELET T, Visentin J, Guidicelli G, Merville P, et al
    Anti-HLA donor-specific antibodies are not created equally. Don't forget the flow....
    Transpl Int. 2016;29:508-10.
    PubMed     Text format    


  81. DEMISELLE J, Augusto JF, Videcoq M, Legeard E, et al
    Transplantation of kidneys from uncontrolled donation after circulatory determination of death: comparison with brain death donors with or without extended criteria and impact of normothermic regional perfusion.
    Transpl Int. 2016;29:432-42.
    PubMed     Text format     Abstract available


  82. ALLEN R, Pleass H, Clayton PA, Woodroffe C, et al
    Outcomes of kidney paired donation transplants in relation to shipping and cold ischaemia time.
    Transpl Int. 2016;29:425-31.
    PubMed     Text format     Abstract available


  83. ESKANDARY F, Wahrmann M, Muhlbacher J, Bohmig GA, et al
    Complement inhibition as potential new therapy for antibody-mediated rejection.
    Transpl Int. 2016;29:392-402.
    PubMed     Text format     Abstract available


    March 2016
  84. WAN SS, Cantarovich M, Mucsi I, Baran D, et al
    Early Renal Function Recovery and Long-term Graft Survival in Kidney Transplantation.
    Transpl Int. 2016 Mar 14. doi: 10.1111/tri.12775.
    PubMed     Text format     Abstract available


  85. NICLAUSS N, Bedat B, Morel P, Andres A, et al
    Impact of graft implantation order on graft survival in simultaneous pancreas-kidney transplantation.
    Transpl Int. 2016 Mar 14. doi: 10.1111/tri.12773.
    PubMed     Text format     Abstract available


  86. BUNNAPRADIST S, Rostaing L, Alloway RR, West-Thielke P, et al
    LCPT Once-Daily Extended-Release Tacrolimus Tablets Vs. Twice-Daily Capsules: A Pooled Analysis of Two Phase 3 Trials in Important De Novo and Stable Kidney Transplant Recipient Subgroups.
    Transpl Int. 2016 Mar 8. doi: 10.1111/tri.12770.
    PubMed     Text format     Abstract available


  87. MJOEN G, Holdaas H
    Regarding long-term outcome after kidney donation.
    Transpl Int. 2016;29:381.
    PubMed     Text format    


    February 2016
  88. KWONG J, Schiefer D, Aboalsamh G, Archambault J, et al
    Optimal management of distal ureteric strictures following renal transplantation: a systematic review.
    Transpl Int. 2016 Feb 20. doi: 10.1111/tri.12759.
    PubMed     Text format     Abstract available


  89. SVACHOVA V, Sekerkova A, Hruba P, Tycova I, et al
    Dynamic changes of B cell compartments in kidney transplantation: lack of transitional B cells is associated with allograft rejection.
    Transpl Int. 2016 Feb 3. doi: 10.1111/tri.12751.
    PubMed     Text format     Abstract available


  90. SAGASTA A, Sanchez-Escuredo A, Oppenheimer F, Paredes D, et al
    Pre-implantation analysis of kidney biopsies from expanded criteria donors: testing the accuracy of frozen section technique and the adequacy of their assessment by on-call pathologists.
    Transpl Int. 2016;29:234-40.
    PubMed     Text format     Abstract available


    January 2016
  91. QUERARD AH, Foucher Y, Combescure C, Dantan E, et al
    Comparison of survival outcomes between Expanded Criteria Donor and Standard Criteria Donor kidney transplant recipients: a systematic review and meta-analysis.
    Transpl Int. 2016 Jan 12. doi: 10.1111/tri.12736.
    PubMed     Text format     Abstract available


  92. MAKSTEN EF, Vase MO, Kampmann J, d'Amore F, et al
    Post-transplant lymphoproliferative disorder following kidney transplantation: a population-based cohort study.
    Transpl Int. 2016 Jan 8. doi: 10.1111/tri.12744.
    PubMed     Text format     Abstract available


  93. THIERRY A, Lemeur Y, Ecotiere L, Abou-Ayache R, et al
    Minimization of maintenance immunosuppressive therapy after renal transplantation comparing cyclosporine A/azathioprine or cyclosporine A/mycophenolate mofetil bitherapy to cyclosporine A monotherapy: a 10-year postrandomization follow-up study.
    Transpl Int. 2016;29:23-33.
    PubMed     Text format     Abstract available


  94. BIANCONE L, Cozzi E, Lopez-Fraga M, Nanni-Costa A, et al
    Long-term outcome of living kidney donation: Position paper of the European Committee on Organ Transplantation (CD-P-TO), Council of Europe.
    Transpl Int. 2016;29:129-31.
    PubMed     Text format    


  95. PANDANABOYANA S, Longbotham D, Hostert L, Attia M, et al
    Transplantation of liver and kidney from donors with malignancy at the time of donation: an experience from a single centre.
    Transpl Int. 2016;29:73-80.
    PubMed     Text format     Abstract available


  96. FLECHNER SM
    Optimizing immunosuppression: who can do more with less?
    Transpl Int. 2016;29:20-2.
    PubMed     Text format    


    December 2015
  97. NOVOSEL MK, Bistrup C
    Discontinuation of Steroids in ABO Incompatible Renal Transplantation.
    Transpl Int. 2015 Dec 26. doi: 10.1111/tri.12735.
    PubMed     Text format     Abstract available


  98. SANCHEZ-ESCUREDO A, Diekmann F, Revuelta I, Esforzado N, et al
    An mTOR- inhibitors based protocol calcineurin inhibitor (CNI)-free in kidney transplant recipients from donors after cardiac death: Good renal function, but high incidence of conversion to CNI.
    Transpl Int. 2015 Dec 17. doi: 10.1111/tri.12732.
    PubMed     Text format     Abstract available


  99. NAGY K, Ujszaszi A, Czira ME, Remport A, et al
    Association between serum resistin level and outcomes in kidney transplant recipients.
    Transpl Int. 2015 Dec 7. doi: 10.1111/tri.12728.
    PubMed     Text format     Abstract available


    November 2015
  100. ESPOSITO L, Rostaing L, Kamar N
    Successful pregnancy after ABO-incompatible kidney transplantation.
    Transpl Int. 2015 Nov 28. doi: 10.1111/tri.12724.
    PubMed     Text format     Abstract available


  101. DOS SANTOS DC, Campos EF, Saraiva Camara NO, David DS, et al
    Compartment-specific expression of natural killer cell markers in renal transplantation: immune profile in acute rejection.
    Transpl Int. 2015 Nov 28. doi: 10.1111/tri.12726.
    PubMed     Text format     Abstract available


  102. CHAN W, Jones D, Bosch JA, McPhee J, et al
    Cardiovascular, Muscular and Perceptual Contributions to Physical Fatigue in Prevalent Kidney Transplant Recipients.
    Transpl Int. 2015 Nov 28. doi: 10.1111/tri.12727.
    PubMed     Text format     Abstract available


  103. BELLIERE J, Kamar N, Mengelle C, Allal A, et al
    Pilot conversion trial from mycophenolic acid to everolimus in ABO-incompatible kidney-transplant recipients with BK viruria and/or viremia.
    Transpl Int. 2015 Nov 17. doi: 10.1111/tri.12718.
    PubMed     Text format     Abstract available


  104. KRAMER BK, Montagnino G, Kruger B, Margreiter R, et al
    Efficacy and safety of tacrolimus compared with ciclosporin a in renal transplantation: seven-year observational results.
    Transpl Int. 2015 Nov 13. doi: 10.1111/tri.12716.
    PubMed     Text format     Abstract available


  105. SCHMID A
    Percutaneous Renal Transplant Biopsy: Is the safety profile adequate for short term post procedure monitoring?
    Transpl Int. 2015 Nov 13. doi: 10.1111/tri.12713.
    PubMed     Text format     Abstract available


  106. MUNDT HM, Yard BA, Kramer BK, Benck U, et al
    Optimized donor management and organ preservation before kidney transplantation.
    Transpl Int. 2015 Nov 13. doi: 10.1111/tri.12712.
    PubMed     Text format     Abstract available


  107. NAIK AS, Dharnidharka VR, Schnitzler MA, Brennan DC, et al
    Clinical and Economic Consequences of First-Year Urinary Tract Infections, Sepsis and Pneumonia in Contemporary Kidney Transplantation Practice.
    Transpl Int. 2015 Nov 13. doi: 10.1111/tri.12711.
    PubMed     Text format     Abstract available


    July 2015
  108. THOMAS MN, Nadalin S, Schemmer P, Pascher A, et al
    A German survey of the abdominal transplantation surgical work force.
    Transpl Int. 2015;28:849-56.
    PubMed     Text format     Abstract available


  109. VAILAS M, Vernadakis S, Zavos G
    Tuberculous enteritis: a surgical 'Janus' masquerading as intestinal obstruction.
    Transpl Int. 2015;28:872-3.
    PubMed     Text format    


    June 2015
  110. O'NEILL S, Oniscu GC, Harrison EM
    Faster may be better for anastomosis time, but does it really affect survival?
    Transpl Int. 2015;28:764.
    PubMed     Text format    


    May 2015
  111. VAN GELDER T, Hesselink DA
    Mycophenolate revisited.
    Transpl Int. 2015;28:508-15.
    PubMed     Text format     Abstract available


  112. USLU A, Hur E, Sen C, Sen S, et al
    To what extent estimated or measured GFR could predict subclinical graft fibrosis: a comparative prospective study with protocol biopsies.
    Transpl Int. 2015;28:575-81.
    PubMed     Text format     Abstract available


  113. NOCERA A, Cioni M, Tagliamacco A, Comoli P, et al
    Serum complement inactivation unveiled prepregnancy donor-specific HLA antibodies leading to postpartum kidney graft loss.
    Transpl Int. 2015;28:623-5.
    PubMed     Text format    


  114. PIKE TW, Pandanaboyana S, Hope-Johnson T, Hostert L, et al
    Ureteric reconstruction for the management of transplant ureteric stricture: a decade of experience from a single centre.
    Transpl Int. 2015;28:529-34.
    PubMed     Text format     Abstract available


    April 2015
  115. HESSELINK DA
    When a zero mismatch is no longer superior.
    Transpl Int. 2015;28:398-400.
    PubMed     Text format    


  116. SOMMERER C, Feuerstein D, Dikow R, Rauch G, et al
    Psychosocial and physical outcome following kidney donation-a retrospective analysis.
    Transpl Int. 2015;28:416-28.
    PubMed     Text format     Abstract available


    March 2015
  117. VAN BOEKEL GA, Aarnoutse RE, Hoogtanders KE, Havenith TR, et al
    Delayed trough level measurement with the use of prolonged-release tacrolimus.
    Transpl Int. 2015;28:314-8.
    PubMed     Text format     Abstract available


    January 2015
  118. WEISMULLER TJ, Lerch C, Evangelidou E, Strassburg CP, et al
    A pocket guide to identify patients at risk for chronic kidney disease after liver transplantation.
    Transpl Int. 2015 Jan 9. doi: 10.1111/tri.12522.
    PubMed     Text format     Abstract available


    November 2014
  119. THYS K, Schwering KL, Siebelink M, Dobbels F, et al
    Psychosocial impact of pediatric living-donor kidney and liver transplantation on recipients, donors and the family: a systematic review.
    Transpl Int. 2014 Nov 1. doi: 10.1111/tri.12481.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Kidney Transplantation is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: